QUCY
Quantum Cyber N.V.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$48.82M
P/E Ratio
—
EPS
$-2.10
Beta
0.43
52W High
$4.93
52W Low
$0.30
50-Day MA
$0.88
200-Day MA
$1.19
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Quantum Cyber N.V.
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.
Fundamentals
| Revenue (TTM) | 537,080 |
| Gross Profit (TTM) | 389,790 |
| EBITDA | $-12.70M |
| Operating Margin | -2461.00% |
| Return on Equity | -448.00% |
| Return on Assets | -94.30% |
| Revenue/Share (TTM) | $0.07 |
| Book Value | $0.07 |
| Price-to-Book | 10.72 |
| Price-to-Sales (TTM) | 90.90 |
| EV/Revenue | 82.92 |
| EV/EBITDA | -2.83 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -32.90% |
| Shares Outstanding | $14.66M |
| Float | $12.71M |
| % Insiders | 12.67% |
| % Institutions | 2.41% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026